AM CET Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology innovation company, today announced that it will discontinue the Phase 3 UNITY study of efgartigimod ...
Opinion
Cornwall Live on MSNOpinion
South West Water failed to tell public about 3,000 sewage discharges in first six months
'Imagine checking for a sewage alert, heading out for a swim or a surf, and finding sewage has been pouring into the sea for hours but your water company didn't report it' ...
Galderma Presents New Three-Year Nemluvio ® Data Showing Deep and Lasting Skin Lesion and Itch Responses in Patients With Atopic Dermatitis Aged 12 and Older.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results